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Background
Activity of antimicrobial agents may be affected by pul-
monary surfactant. Notably, it was reported that the clini-
cal efficacy of daptomycin is significantly impaired in
pneumonia in spite of bacterial susceptibility in vitro. This
study set out to assess the impact of pulmonary surfactant
in vitro on bacterial killing of other antibiotics used for
treatment of pneumonia.
Methods
Time-kill curves of daptomycin, doripenem, linezolid, mox-
ifloxacin, and tigecycline were determined for Staphylococ-
cus aureus ATCC 29213 and of colistin, doripenem and
moxifloxacin for a clinical isolate of Pseudomonas aerugi-
nosa at concentrations above or equal to the respective
MICs. All experiments were performed over 24 h in Muel-
ler-Hinton broth (MHB) and in MHB enriched with por-
cine surfactant at a concentration of 1 mg/mL (MHBsurf).
Results
As expected, daptomycin was not bactericidal in pre-
sence of surfactant at concentrations up to 64 times the
MIC. In MHBsurf a higher concentration of moxifloxacin
(16x) was needed than in MHB (2x MIC) to achieve
sustained bacterial killing of S. aureus. In contrast, kill-
ing of P. aeruginosa by moxifloxacin was not affected by
surfactant. A slightly higher concentration of doripenem
(8x) was needed in MHBsurf to achieve sustained antimi-
crobial killing against S. aureus than in MHB (4x MIC).
However, killing was faster in MHBsurf. Similarly, initial
killing of S. aureus by tigecycline was faster in MHBsurf
than in MHB while after 24 hours no difference in
bacterial counts was observed between MHB and
MHBsurf. For linezolid no significant effects were
observed by adding surfactant. Likewise, surfactant had
no significant influence on the activity of colistin and
doripenem against P. aeruginosa.
Conclusions
The activity of moxifloxacin against S. aureus was reduced
in vitro by addition of surfactant whereas this effect could
not be observed against P. aeruginosa. Interestingly, anti-
microbial killing by several antibiotics of Gram-positive
S. aureus, but not of Gram-negative P. aeruginosa tended
to be faster in presence of surfactant. Thus, apart from
daptomycin, pulmonary surfactant is also capable of influ-
encing the bacterial killing kinetics of several other anti-
biotics. The clinical relevance of these in vitro findings for
pneumonia patients is currently unclear, and should be
carefully evaluated.
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